Latest California Healthline Stories
Sen. Ed Hernandez is in a public spat with the Indianapolis drugmaker over the company’s refusal to heed a state law requiring advance notice — and justification — of large drug price hikes. The company says it is awaiting a court decision on the law’s constitutionality.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
In a major coup for the beverage industry, California lawmakers agreed to ban cities and counties from adopting soda taxes for the next 12 years. In exchange, the beverage industry agreed to pull an initiative off the November ballot that, if passed, would have made it much harder for local governments to raise taxes.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
On April 1, Medicare launched a major initiative — a diabetes prevention program for seniors and people with serious disabilities— that is available in only a few cities.
A Bay Area public health campaign harnesses the power of poetry to confront the root causes of a diabetes epidemic that is disproportionately hitting minority youth and those from low-income homes.
Kaiser Health News Editor-in-Chief Elisabeth Rosenthal discussed drug costs with Scott Simon, the host of NPR’s Weekend Edition on Saturday, Feb. 10. This is a transcript of that conversation.
From infections linked to the storm to trying to treat people with chronic diseases in damaged clinics, health officials on this American territory struggle to stay ahead of the needs.
The market for wound care products booms among a growing older and diabetic patient pool, but many treatments are untested and funding for research falls short.